Ask AI

Myeloma Masterclass: Adopting the Latest Guidelines for Evidence-Based, Equitable Care

Deepen your understanding of the latest clinical data and guideline recommendations for multiple myeloma treatment regimens across the disease continuum to develop individualized care plans and optimize patient outcomes through an expert-written ClinicalThought commentary and certified on-demand webcast with accompanying downloadable slides.

Share

Program Content

Events

Activities

Smoldering Multiple Myeloma
Evaluating and Managing Smoldering Multiple Myeloma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 29, 2026

Treatment of Newly Diagnosed MM
MM Confirmed: What Are Next Steps for Optimal Treatment of NDMM?
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 29, 2026

Treatment of Relapsed Refractory MM
Updates on New Treatment Options for Previously Treated MM: Optimizing Therapy Sequencing in R/R MM
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 29, 2026

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network (NCCN) in collaboration with Decera Clinical Education.

Supporters

Supported by educational grants from AstraZeneca and Johnson & Johnson.
This educational activity is supported by an independent medical education grant from GSK.

AstraZeneca

GSK

Johnson & Johnson

Partners

Decera Clinical Education

ProCE Banner